University of California San Francisco

Allison Webber - 144
Allison
Webber
MD

 

Clinical Professor of Medicine, Division of Nephrology
UCSF Connie Frank Kidney Transplant Center

 

Address

400 Parnassus Avenue, #A730F
San Francisco, CA 94117
United States

Phone: 415-353-1551
Fax: 415-353-8381

Biography

Allison Webber, M.D. joined UCSF Department of Medicine- Nephrology in 2009 after completing her training at the New York Presbyterian Hospital- Weill Cornell Medical Center in General and Transplant Nephrology. She has had various leadership positions, including her role as the post-kidney transplant clinic director from 2010-2018.

Dr. Webber runs a monthly kidney transplant conference with the general and transplant nephrology fellows where transplant-related concepts including: immunosuppressive drugs, rejection, transplant histopathology, immunology, and infectious complications are reviewed.

Her research interests include immune monitoring and antibody mediated rejection in kidney transplantation, and she is a co-principal investigator or co-investigator on several industry and government sponsored studies in these areas.

Recently she has taken an interest in developing a program for kidney transplantation for patients with end stage renal disease from multiple myeloma. Partnering with her oncology colleagues, she has developed a protocol for transplantation specifically for this patient population.

Education

Institution Degree Dept or School End Date
New York Presbyterian Hospital Weill Cornell Medical Center Transplant Medicine 6/2009
New York Presbyterian Hospital Weill Cornell Medical Center Nephrology 6/2008
New York Downtown Hospital Chief Resident 6/2006
NY Presbyterian Hospital Weill Cornell Medical Center Internal Medicine Residency 6/2005
Albert Einstein College of Medicine M.D. Medicine 6/2002
University of Pennsylvania B.A. English/Pre-Med 5/1997

Board Certifications

  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Nephrology Subspecialty

Clinical Expertise

Kidney Transplantation
Transplant Nephrology
Chronic Kidney Disease
End Stage Renal Disease (Kidney Failure)
Living Kidney Donor Transplantation
Acute Kidney Injury

Research Interests

Immune monitoring

Urinary biomarkers

Primary nonfunction

Post-transplantation collapsing glomerulopathy

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 22
  1. Diabetes Insipidus in Deceased Donors and Outcomes in Kidney Transplant Recipients.
    Nunez M, Gardner J, Syed S, Webber A, Shoji J, Copeland TP, McCulloch CE, Ku E, Roll GR| | PubMed
  2. Transplant Onconephrology in Patients With Kidney Transplants.
    Murakami N, Webber AB, Nair V| | PubMed
  3. Outcomes of kidney transplant recipients with ESKD due to plasma cell dyscrasia: A case series.
    Dinh AR, Wong SW, Martin TG, Wolf JL, Webber AB| | PubMed
  4. COVID-19 and Abdominal Transplant: A Stepwise Approach to Practice During Pandemic Conditions.
    Syed SM, Gardner J, Roll G, Webber A, Mehta N, Shoji J, Adelmann D, Niemann C, Braun HJ, Mello A, Yao F, Posselt A, Kang SM, Hirose R, Roberts J, Feng S, Ascher N, Stock P, Freise C| | PubMed
  5. A Virtual Crossmatch-based Strategy Facilitates Sharing of Deceased Donor Kidneys for Highly Sensitized Recipients.
    Roll GR, Webber AB, Gae DH, Laszik Z, Tavakol M, Mayen L, Cunniffe K, Syed S, Hirose R, Freise C, Feng S, Roberts JP, Ascher NL, Stock PG, Rajalingam R| | PubMed
  6. Successful Deceased Donor Kidney Transplantation of Highly Sensitized Candidates Across Positive Cross Match and Strong Donor-Specific HLA-DP Antibodies without Desensitization.
    Raja Rajalingam, David D Gae, Zoltan G Laszik, Mehdi M Tavakol, Allison B Webber, Deján Dobi, Kelly Cunniffe, Gilberto da Gente, Ryutaro Hirose, Garrett Roll, John P Roberts| | UCSF Research Profile
  7. Nuclear Factor of Activated T Cell-regulated Cytokine Gene Expression for Adjustment of Tacrolimus in Kidney Transplant Recipients: A Randomized Controlled Pilot Trial.
    Webber AB, Tatapudi V, Maw TT, Peralta C, Leung JCY, Vincenti F| | PubMed
  8. Kidney Transplantation for Kidney Failure Due to Multiple Myeloma: Case Reports.
    Le TX, Wolf JL, Peralta CA, Webber AB| | PubMed
  9. An Update on Calcineurin Inhibitor-Free Regimens: The Need Persists, but the Landscape has Changed.
    Webber AB, Vincenti F| | PubMed
  10. An unusual case of ischemic nephropathy.
    Ledesma Y, Parekh J, Maw TT, Webber A| | PubMed
  11. Future Pathways for Immune Manipulation.
    Allison B. Webber, Flavio Vincenti| | UCSF Research Profile
  12. Everolimus Conversion to Treat BK Virus Infection in Renal Transplant Recipients: Interim Analysis of a Pilot Study.
    D. Wojciechowski, A. Webber, S. Chandran, R. Hirose, F. Vincenti| | UCSF Research Profile
  13. Feasibility of Adjustment of Immunosuppression Based On NFAT-Dependent Cytokine Gene Expression Levels in Kidney Transplant Patients - Interim Analysis.
    T. Maw, A. Webber, C. Leung, R. Hirose, F. Vincenti| | UCSF Research Profile
  14. Pharmacodynamic Monitoring of NFAT- Regulated Gene Expression and P70S6 Kinase Activity in Kidney Transplant Patients With BKV Infection.
    A. Webber, D. Wojciechowski, C. Leung, S. Chandran, R. Hirose, F. Vincenti| | UCSF Research Profile
  15. Prediabetic living kidney donors have preserved kidney function at 10 years after donation.
    Chandran S, Masharani U, Webber AB, Wojciechowski DM| | PubMed
  16. Fatal transplant-associated west nile virus encephalitis and public health investigation-california, 2010.
    Rabe IB, Schwartz BS, Farnon EC, Josephson SA, Webber AB, Roberts JP, de Mattos AM, Gallay BJ, van Slyck S, Messenger SL, Yen CJ, Bloch EM, Drew CP, Fischer M, Glaser CA, WNV Transplant Investigation Team| | PubMed
  17. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year.
    Wojciechowski D, Chanda R, Chandran S, Lee B, Webber A, Macaraig M, Tomlanovich S, Vincenti F| | PubMed
  18. Mean arterial blood pressure while awaiting kidney transplantation is associated with the risk of primary nonfunction.
    Webber A, Hambleton J, Chami A, Bang H, Seshan S, Sharma A, August P, Kapur S, Suthanthiran M, Dadhania D| | PubMed
  19. Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report.
    Chandran S, Baxter-Lowe L, Olson JL, Tomlanovich SJ, Webber A| | PubMed
  20. Novel strategies in immunosuppression: issues in perspective.
    Webber A, Hirose R, Vincenti F| | PubMed
  21. Managing the atazanavir-tacrolimus drug interaction in a renal transplant recipient.
    Tsapepas DS, Webber AB, Aull MJ, Figueiro JM, Saal SD| | PubMed
  22. The Case | Triple acid-base disorder after drug abuse.
    Jhaveri KD, Webber AB| | PubMed